News of the Day

  • New York Doctor Tests Positive for Ebola

    A doctor who had returned to New York City recently after treating Ebola patients in West Africa tested positive for the virus on Thursday, officials said, setting up a new front in the nation’s attempt to control the spread of the deadly disease.Craig Spencer, a 33-year-old physician who had worked with Doctors Without Borders in Guinea until returning to the U.S. a week ago, is the fourth patient to be diagnosed with Ebola in the U.S. and the ninth to be treated here.

  • Officials Tracing New York Ebola Patient’s Movements, While Reassuring a Wary City

    One city official said the authorities used Dr. Spencer’s phone to track his movements and potential contacts and to corroborate the account he has given to health investigators. The official said that the doctor had been very cooperative and that the information he had given had proven very reliable. But the official noted that memory, particularly in stressful situations, is an imperfect tool, and the doctor’s phone, credit cards and other materials have been useful to fill out his account.

  • Global stocks rattled by Ebola case in New York

    Global stock markets retreated Friday as the first case of Ebola in New York overshadowed positive economic news.The announcement of the first confirmed case of Ebola in New York offset upbeat news about the economy and business, such as healthy earnings reports in the U.S. and a better-than-expected purchasing managers' index from the European Union. South Korea's third quarter growth slowed to 3.2 percent but a rebound in consumer spending was a positive sign to the economy.

  • Study to Look at Blood Products From Ebola Survivors as Treatment

    Researchers plan to test the effectiveness of transfusing blood products from Ebola survivors into infected patients, as a potential near-term countermeasure to the outbreak in West Africa.The treatment has been used experimentally on several patients in the current outbreak, including a handful of Americans. But it hasn’t been rigorously studied until now.The European Commission said Thursday it is providing €2.9 million, or about $3.7 million, to fund a clinical trial to be led by the Institute of Tropical Medicine in Antwerp, Belgium. The U.K.’s Wellcome Trust is providing additional support to the effort, including coordinating efforts by various government and private organizations that will be involved in the project.

  • US Defense Department Spent $140M On Ebola Treatment Research -- And They're Getting Close

    The tragic Ebola outbreak in the African nation of Guinea in recent days is devastating to local communities but has presented a rare opportunity to advance the pursuit of a cure. The epidemic has cost the lives of 83 people so far out of 127 total cases reported.There are no approved treatments for the virus yet but one Canadian company called Tekmira Pharaceuticals Corp. has come close. And industry insiders buzzing about using the as-yet unlicensed anti-viral drug to help patients in Guinea.

  • Private Funding Aids Ebola Fight

    Facebook founder and CEO Mark Zuckerberg and his wife, Dr. Priscilla Chan, drew attention to the CDC Foundation last week when they contributed $25 million to aid the fight against Ebola. Their high-profile donation has brought attention to the crisis in West Africa and caused an uptick in individual donations.The CDC Foundation – a nonprofit, independent organization that connects the Centers for Disease Control and Prevention with private donors – had received $52,000 in individual contributions from approximately 275 donations through Oct. 13 after it activated the Global Disaster Response Fund in early August.

  • Fighting Ebola - A Disease Without Borders

    To support global efforts in the fight against Ebola, all trade commissions will be donated to Doctors Without Borders.1 Ebola has so far managed to infect a few thousand people around the world, with the majority of those contracting the disease located in West Africa.2 However, the disease has an estimated fatality rate of 50%, and this latest outbreak is the largest ever. The CDC indicated a worst-case scenario projection has estimated that as many as 1.4 million people in Liberia and Sierra Leone could be stricken with Ebola by January 2015, while a best case scenario would be ending nearly all cases.

  • US stocks and sectors to watch after NY Ebola case

    A New York doctor has tested positive for the Ebola virus after returning from treating patients in West Africa, it was announced late Thursday. News of the case has pushed shares in Asia and Europe lower and now all eyes on the U.S.As U.S. futures broadly point to a lower open, CNBC asked a group of global equity strategists to pick out the U.S. sectors and stocks that could be affected during Friday's trading session.

  • Paul Allen to Give $100 Million to Tackle Ebola Crisis

    The billionaire Paul G. Allen said on Thursday that he would donate $100 million to the fight against Ebola, which has killed almost 5,000 people so far and crippled Western Africa.The amount roughly quadruples his earlier commitment of about $26 million to nonprofit groups and government agencies like the Centers for Disease Control and Prevention, making him one of the largest individual donors in the Ebola crisis.

  • NYC Ebola Patient Took An Uber Before Going To The Hospital

    The doctor who treated Ebola patients in Guinea and tested positive for the virus on Thursday evening while in isolation at New York City's Bellevue Hospital likely took an Uber yesterday to a Williamsburg bowling alley.Since Ebola is only transmitted by direct contact with bodily fluids or contaminated surfaces and the doctor reportedly self-quarantined himself as soon as he became symptomatic, the risk of transmission via the Uber car is very low. Still, the city's disease investigators may reach out to those who took the same car if they decide there is even a small risk.

  • Ford earnings fall in Q3 amid record product launches

    Ford earned $835 million in the third quarter, down 34% from $1.3 billion a year ago, as sales and profits in North America felt the short-term impact of an aggressive year of product launches.The $1.2-billion pretax profit, substantially below $2.6 billion a year ago, translated to 24 cents per share. That beat analyst estimates of 19 cents.Revenue dipped slightly from $36 billion a year earlier to $35 billion. Almost all regions saw a drop in earnings.Lower volume, higher recall costs in North America and the effects of adverse exchange rates in South America are to blame for the lower earnings in the quarter, CEO Mark Fields told analysts

  • Made in Michigan : Oppos leggings for girls

    One morning in early 2013 while sitting in her grandfather's kitchen, 10-year-old Josie Ervin suggested that together she and her grandpa launch a line of girls leggings featuring interchangeable legs. Tom Ervin, a born entrepreneur, encouraged his young granddaughter to keep talking. The more he heard, the more he realized she was on to something big. Not long after, OPPOS was born.

Payne's Pros